使用博尔特佐米布成功治疗富含血细胞的急性排斥:一个案例报告
Sara Hashemi1, Reut Hod-Dvorai2, Rebecca Tong2
1Division of Nephrology and Transplantation The State University of New York Upstate Medical University (SUNY Upstate Medical University), Syracuse, New York 13210, USA.
Case reports in transplantation
|September 16, 2024
概括
富含血细胞的急性排斥 (PCAR) 很难治疗. 这份病例报告显示,博雷佐米布可以有效治疗PCAR,改善移植结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 富含血细胞的急性排斥 (PCAR) 是一种罕见但严重的移植排斥形式.
- PCAR的特点是血细胞透率超过10%,治疗反应不佳,移植失败率高.
- 目前缺乏PCAR的治疗标准.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
10:26In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
12.1K
